SEPTEMBER 13-14, 2021 | VIRTUAL EVENT

Carve-outs, estoppel, restrictions on venue, and ANDA litigation remain some of the hottest contested issues under Paragraph IV of the Hatch-Waxman Act. Via Momentum’s fully interactive platform, join us as our conference faculty of esteemed judges, leading in-house counsel and experienced practitioners provide you with the tactics, tools, strategies and insight you need when litigating Paragraph IV cases.

SPEAKER HIGHLIGHTS

Honorable Michelle N. Ankenbrand
Honorable Michelle N. Ankenbrand
Lead Administrative Patent Judge

USPTO

Honorable Jacqueline Wright Bonilla
Honorable Jacqueline Wright Bonilla
Deputy Chief Administrative Patent Judge, Patent Trial and Appeal Board

USPTO

Arlene Chow
Arlene Chow
Partner

LATHAM & WATKINS LLP

Ryan Coletti
Ryan Coletti
Vice President, Intellectual Property and Litigation

SHIONOGI INC.

Betsy Flanagan
Betsy Flanagan
Principal

FISH & RICHARDSON P.C.

John Haberman
John Haberman
Senior Director, IP

SAREPTA THERAPEUTICS

Jake M. Holdreith
Jake M. Holdreith
Partner, Member of the Executive Board

ROBINS KAPLAN LLP

John Kirkland
John Kirkland
Senior Director of IP and Litigation

ALKERMES

Brian Malkin
Brian Malkin
Partner

MCDERMOTT WILL & EMERY LLP

Donna Meuth
Donna Meuth
Associate General Counsel Intellectual Property

EISAI

Paul Molino
Paul Molino
Partner

RAKOCZY MOLINO MAZZOCHI SIWIK LLP

Kevin E. Noonan
Kevin E. Noonan
Partner

MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP

Honorable Kristi Rupert Sawert
Honorable Kristi Rupert Sawert
Administrative Patent Judge

USPTO

Laura Shores
Laura Shores
Partner

ARNOLD & PORTER LLP

Sanya Sukduang
Sanya Sukduang
Partner

COOLEY LLP

Bruce Wexler
Bruce Wexler
Partner

PAUL HASTINGS LLP

Ha Kung Wong
Ha Kung Wong
Partner

VENABLE LLP

Top Reasons to Attend

  1. Obtain the thoughts of Federal Circuit and PTAB Judges regarding to best practices when arguing a case related to pharmaceutical IP
  2. Put the outcomes of “GSK v. Teva” and “Minerva Surgical v Hologic Inc” into use as you prepare for upcoming Paragraph IV litigation
  3. Strengthen your abilities to protect company intellectual property overseas by examining current international regulations and court rulings
  4. Further understand how President Biden’s potential waiver in the fight against COVID-19 may affect the IP rights of pharmaceuticals and biologics going forward
  5. Network with leading Paragraph IV experts to ready yourself for future litigation

WHO SHOULD ATTEND

Professionals from Pharmaceutical and Medical Device Companies with Titles Including:

  • Associate General Counsel, Litigation
  • Associate General Counsel, IP
  • Patent Counsel
  • Senior Legal Counsel
  • Vice-President, Intellectual Property
  • Director, Intellectual Property
  • General Counsel
  • Head of Intellectual Property

SILVER SPONSOR

Supporting Sponsor

2021 SPONSORSHIP OPPORTUNITIES

Sponsorship is a great way to enhance your brand’s visibility and help you connect with top-level decision-makers, innovators, and industry disruptors. There are a number of ways to maximize branding opportunities at the summit.

To learn about sponsorship opportunities, please contact Shelly Urish at shelly@momentumevents.com

NETWORKING CAPABILITIES

✔ Virtual Matchmaking: Visit our virtual lobby and connect with fellow attendees using our platform’s matchmaking technology. You can chat, video, and even make a list of the people you want to meet and the knowledge you’re looking to gain through our bespoke 1:1 match-making services

✔ Roundtable Networking throughout the Summit will give you the chance to connect and meet in-depth your fellow attendees as well as our Sponsors and Speakers

✔ The platform we use allows us to make polls, QA, and chat during the sessions.

✔ Virtual Happy Hour: Grab a drink and bring it to your screen to cheers from afar while continuing to chat with and get to know your fellow conference participants.

Pricing

In-House Rate

Law Firms and Service Providers

GROUP DISCOUNTS AVAILABLE!

Contact Frank Fernandez at frank@momentumevents.com to get more information.

Click here to view the cancellation/refund/transfer policy